ReviewCancers2025
Evolving and Novel Applications of Artificial Intelligence in Cancer Imaging.
Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Comprehensive overview of AI methodologies in nano-drug delivery Optimization and Design.NPJ precision oncology · 2026Review
- A perioperative multi-modal fusion and deep learning-based prognostic system for upper tract urothelial carcinoma: a multi-institutional study.Insights into imaging · 2026Article
- A bibliometric analysis of artificial intelligence in ovarian cancer research from 2006 to 2025.Discover oncology · 2026Article
- Advancements in Skeletal Tumour Management: Linking Metastatic Biology With Surgical Reconstruction.Cureus · 2026Review
- Comparative Molecular Insights and Computational Modeling of Multiple Myeloma and Osteosarcoma.International journal of molecular sciences · 2026Review
- Artificial Intelligence in the Diagnosis and Prognostic Stratification of Hepatocellular Carcinoma: Current Evidence, Clinical Applications, and Future Perspectives.Biomedicines · 2026Review
- Overcoming domain-specific challenges for artificial intelligence in abdominal oncology toward clinical translation.Discover oncology · 2026Review
- Large Language Models for Non-Coding RNA Biomarker Discovery in Breast Cancer.Methods in molecular biology (Clifton, N.J.) · 2026Article
- Artificial Intelligence and Radiomics in Primary Liver Cancer Imaging: A Bibliometric and Visualized Analysis.Journal of hepatocellular carcinoma · 2026Article
- Editorial: Advancing cancer imaging technologies: bridging the gap from research to clinical practice.Frontiers in oncology · 2026Article
- Multi-class brain tumor MRI segmentation and classification using deep learning and machine learning approaches.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025Article
- Advancing Neurosurgical Oncology and AI Innovations in Latin American Brain Cancer Care: Insights from a Center of Excellence.NeuroSci · 2025Review
- Addressing the current challenges in the clinical application of AI-based Radiomics for cancer imaging.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is revolutionizing cancer imaging, enhancing screening, diagnosis, and treatment options for clinicians. AI-driven applications, particularly deep learning and machine learning, excel in risk assessment, tumor detection, classification, and predictive treatment prognosis. Machine learning algorithms, especially deep learning frameworks, improve lesion characterization and automated segmentation, leading to enhanced radiomic feature extraction and delineation. Radiomics, which quantifies imaging features, offers personalized treatment response predictions across various imaging modalities. AI models also facilitate technological improvements in non-diagnostic tasks, such as image optimization and automated medical reporting. Despite advancements, challenges persist in integrating AI into healthcare, tracking accurate data, and ensuring patient privacy. Validation through clinician input and multi-institutional studies is essential for patient safety and model generalizability. This requires support from radiologists worldwide and consideration of complex regulatory processes. Future directions include elaborating on existing optimizations, integrating advanced AI techniques, improving patient-centric medicine, and expanding healthcare accessibility. AI can enhance cancer imaging, optimizing precision medicine and improving patient outcomes. Ongoing multidisciplinary collaboration between radiologists, oncologists, software developers, and regulatory bodies is crucial for AI's growing role in clinical oncology. This review aims to provide an overview of the applications of AI in oncologic imaging while also discussing their limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.